AI Assistant
Blog
Pricing
Log In
Sign Up
MP57-19 TIM-3 AND TIGIT ARE POTENTIAL IMMUNE CHECKPOINT TARGETS IN PATIENTS WITH BLADDER CANCER
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
